Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Data Published in New England Journal of Medicine Demonstrate the Vaccine’s Immunogenicity

Pfizer Inc. (NYSE: PFE) today announced that detailed results from two
pivotal Phase 3 studies of TRUMENBA® (Meningococcal …

Pfizer Inc. (NYSE: PFE) today announced that detailed results from two pivotal Phase 3 studies of TRUMENBA® (Meningococcal ...